NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · IEX Real-Time Price · USD
2.200
+0.030 (1.38%)
Jun 14, 2024, 10:46 AM EDT - Market open

NEXGEL Revenue

NEXGEL had revenue of $4.74M in the twelve months ending March 31, 2024, with 108.36% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.27M with 104.19% year-over-year growth. In the year 2023, NEXGEL had annual revenue of $4.09M with 99.66% growth.

Revenue (ttm)
$4.74M
Revenue Growth
+108.36%
P/S Ratio
2.96
Revenue / Employee
$249,263
Employees
19
Market Cap
13.39M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.09M2.04M99.66%
Dec 31, 20222.05M497.00K32.04%
Dec 31, 20211.55M877.00K130.12%
Dec 31, 2020674.00K-43.00K-6.00%
Dec 31, 2019717.00K-1.50M-67.60%
Dec 31, 20182.21M221.00K11.09%
Dec 31, 20171.99M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Flora Growth 74.78M
Psychemedics 21.60M
Mainz Biomed B.V. 895.48K
Organovo Holdings 109.00K
Cardio Diagnostics Holdings 32.99K
Revenue Rankings